Table 4.
Bleeding complications and postpartum anticoagulation
| Parameter | Prophylaxis n=13 | Therapeutic n=40 |
|---|---|---|
| Switched to heparin sodium for delivery (n,%) | (n=12) * 5 (38.5%) | (n=36) ‡ 10 (27.8%) |
| Time from last injection to delivery (hours, mean ± SD, range) | n = 11 † 48 ± 12 (20–168) |
n = 33 † 38 ± 25 (6–144) |
| Time from delivery until anticoagulation restarted (hours, avg ± SD range) | n = 10 37 ± 42 (12 – 52) |
n=35 17 ± 10 (3 – 48) |
| Postpartum anticoagulation (n, %) | n = 12 | n = 39 |
| LMWH alone | 0 | 4 (10%) |
| LMWH and warfarin | 9 (75%) | 30 (77%) |
| LMWH, warfarin, and heparin | 1 (8.3%) | 2 (5.1%) |
| None | 2 (16.7%) | 0 |
| Heparin + warfarin | 0 | 3 (7.7%) |
| Major Bleeding (n, %) | 2 (15.4%) | 1 (2.5%) |
| Minor Bleeding (n, %) | 2 (15.4%) | 8 (20%) |
| Bruising (n, %) | 4 (30.8%) | 22 (55%) |
| Thromboembolism (n, %) | 1 (7.7%) | 1 (2.5%) |
n = 12 since one patient transferred her care to another facility at 28 weeks
n = 11, data missing on remaining 2 patients
n = 36 since 2 patients terminated pregnancy, 1 patient had therapy discontinued before delivery and 1 patient lost to follow up